Bufa-20,22-dienolide, 1,3,14-trihydroxy-, (1β,3β,5β)- - Names and Identifiers
Bufa-20,22-dienolide, 1,3,14-trihydroxy-, (1β,3β,5β)- - Physico-chemical Properties
Molecular Formula | C24H34O5
|
Molar Mass | 402.53 |
Density | 1.289±0.06 g/cm3(Predicted) |
Melting Point | 196-197 °C |
Boling Point | 595.8±50.0 °C(Predicted) |
pKa | 14.65±0.70(Predicted) |
Storage Condition | 2-8℃ |
Bufa-20,22-dienolide, 1,3,14-trihydroxy-, (1β,3β,5β)- - Introduction
1 beta-hydroxybufalin (1beta-Hydroxybufalin) is an alkaloid, which belongs to a class of bufalin compounds.
Properties: 1 beta-hydroxybufalin is a colorless crystal with a strong bitter taste. It is almost insoluble in water at normal temperature, but soluble in organic solvents such as alcohols, ethers and ketones. Its melting point is 100-105 degrees Celsius.
Purpose: 1 beta-hydroxybufalin has important applications in medicine. It is used to treat cardiovascular diseases such as heart failure and angina. In laboratory studies, it has also been used to study tumor treatment and anti-cancer effects.
Preparation method: The synthesis of 1 beta-hydroxybufalin is generally achieved by chemical reaction. The common preparation method is to use bufaloxin or its derivatives as starting materials, through a series of chemical conversion reactions to obtain the target product. The preparation process needs to pay attention to safety protection, the use of chemicals to follow the relevant laboratory practices.
Safety information: 1 beta-hydroxybufalin is a toxic substance. Exposure or ingestion may cause serious toxic effects on the human body. In the process of use, the dosage and use method must be strictly controlled, and the relevant safety operation regulations must be followed. Any laboratory work with this substance should be carried out under the guidance of experienced and specialized personnel. Wear protective glasses and gloves during handling, and ensure that the workplace is well ventilated. In the event of inadvertent contact or ingestion, seek medical attention immediately and inform your doctor of the details of the substance.
Last Update:2024-04-09 19:05:57